A Pan-Histone Deacetylase Inhibitor Enhances the Antitumor Activity of B7-H3-specific CAR-T Cells in Solid Tumors

CONCLUSIONS: Our results show that our novel strategy which combines SAHA and B7-H3.CAR-T cells enhances their therapeutic efficacy with solid cancers and justify its translation to a clinical setting.PMID:33811153 | DOI:10.1158/1078-0432.CCR-20-2487
Source: Clinical Cancer Research - Category: Cancer & Oncology Authors: Source Type: research